George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 75,000 shares at $43.11 ($3.2M) on 2022-11-21, disclosed to the SEC on 2022-11-22.
Open-market sale of $3.2M RPRX by EVP, Investments & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.11 | 3,100 | $134K | 4.1% |
| 2 | $43.11 | 20,531 | $885K | 27.4% |
| 3 | $43.11 | 20,531 | $885K | 27.4% |
| 4 | $43.14 | 1,900 | $82K | 2.5% |
| 5 | $43.19 | 14,469 | $625K | 19.3% |
| 6 | $43.19 | 14,469 |
| $625K |
| 19.3% |
| Total | $43.14 avg | 75,000 | $3.2M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |